oral semaglutide novo nordisk novonordisk has received European Commission approval for Wegovy® pill, the European Union's first GLP-1 receptor agonist for chronic weight management. The once-daily oral is approved for adults with obesity or Oral Semaglutide Demonstrates Greater Weight

The safety and efficacy of tirzepatide in pediatric populations have not been established, as there have been no well-controlled clinical trials evaluating its effects in children

MCH1R antagonists have also been shown to be efficacious in animal models of depressive behavior although the precise mechanism for the antidepressant effects are not yet clearly defined

The broader theme is immune regulation, not one peptide solving every inflammatory pattern

Medical Conditions: Inform the healthcare provider of any pre-existing conditions, especially issues related to heart, kidney, or liver health

Find alternative ways to soothe emotions: If we can find alternative behaviours or habits, known as substitutions, to soothe challenging emotions, we can move away from emotional eating